Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Spironolactone

A steroidal aldosterone antagonist discovered in 1957 and introduced in 1959; it is a potassium-sparing diuretic used for heart failure, resistant hypertension, fluid build-up from liver or kidney disease and low potassium. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?The name describes its structure: "spiro" means that a lactone ring is attached to the steroid skeleton through a single shared atom, a so-called spiro junction.

SpironolactoneGo to the active ingredient →

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Reference substanceCanrenone CRSEDQM code C0410000Family Spironolactone

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.